A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...
"People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of ...
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...
People with intermediate-risk scores on coronary artery calcium testing who received statins and intensive health coaching ...
K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
23h
Zacks Investment Research on MSNCan BIIB's New Drugs Revive Growth as Multiple Sclerosis Sales Fall?Sales of Biogen’s BIIB key multiple sclerosis (“MS”) drugs like Tecfidera and Tysabri and spinal muscular atrophy (SMA) treatment, Spinraza, are being hurt due to competitive pressure, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results